Bon Natural Life
BON
0 hedge funds and large institutions have $0 invested in Bon Natural Life in 2024 Q3 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, reducing their positions, and 1 closing their positions.
0.2% less ownership
Funds ownership: 0.2% → 0% (-0.2%)
100% less funds holding
Funds holding: 1 → 0 (-1)
100% less capital invested
Capital invested by funds: $167K → $0 (-$167K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$167K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
UBS Group
Zurich,
Switzerland
| – | -$167K | -2,758 | Closed |
|
BON Hedge Fund Activity: Q3 2024 in Review
0 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Bon Natural Life (BON) for Q3 2024, worth a combined $0 — down 100% from $167K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of BON and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest seller was UBS Group, exiting entirely with an estimated $167K sold.
- 0 institutional investors held Bon Natural Life (BON) as of Q3 2024, down from 1 in Q2 2024.
- Funds reported $0 of Bon Natural Life stock for Q3 2024, down 100% quarter-over-quarter.
- 0 funds opened new Bon Natural Life positions in Q3 2024 and 1 closed out, a net change of -1 holder.
- The largest Bon Natural Life seller in Q3 2024 was UBS Group, an estimated $167K sold.
Based on aggregated 13F filings for Q3 2024.